{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T14:01:11Z","timestamp":1787666471698,"version":"build-2736575974"},"reference-count":31,"publisher":"Informa UK Limited","issue":"2","license":[{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Novo Nordisk, Inc"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Pharmacoeconomics & Outcomes Research"],"published-print":{"date-parts":[[2026,2,7]]},"DOI":"10.1080\/14737167.2025.2610206","type":"journal-article","created":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T14:51:12Z","timestamp":1768229472000},"page":"289-301","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":3,"title":["Real-world healthcare resource utilization and medical costs in patients with overweight or obesity and multimorbidity treated with semaglutide in the United States"],"prefix":"10.1080","volume":"26","author":[{"given":"Prachi","family":"Arora","sequence":"first","affiliation":[{"name":"Novo Nordisk Inc","place":["Plainsboro, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Firas","family":"Dabbous","sequence":"additional","affiliation":[{"name":"Thermo Fisher Scientific Inc","place":["Waltham, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sariya","family":"Udayachalerm","sequence":"additional","affiliation":[{"name":"Thermo Fisher Scientific Inc","place":["Waltham, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Saiontz-Martinez","sequence":"additional","affiliation":[{"name":"Thermo Fisher Scientific Inc","place":["Waltham, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenxiang","family":"Zhao","sequence":"additional","affiliation":[{"name":"Novo Nordisk Inc","place":["Plainsboro, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Briain","family":"O Hartaigh","sequence":"additional","affiliation":[{"name":"Formerly Employed by Novo Nordisk, Inc","place":["Plainsboro, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Fabricatore","sequence":"additional","affiliation":[{"name":"Novo Nordisk Inc","place":["Plainsboro, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Bassan","sequence":"additional","affiliation":[{"name":"Formerly Employed by Novo Nordisk, Inc","place":["Plainsboro, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Alvarez","sequence":"additional","affiliation":[{"name":"Formerly Employed by Novo Nordisk, Inc","place":["Plainsboro, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Fitch","sequence":"additional","affiliation":[{"name":"knownwell Medical Clinic","place":["Needham, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,1,12]]},"reference":[{"key":"e_1_3_7_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(25)00397-6"},{"key":"e_1_3_7_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2024.102848"},{"key":"e_1_3_7_5_1","unstructured":"Overweight & Obesity Statistics [Internet]. Washington (DC): National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); 2021 Sep [cited 2024 May 12]. Available from: https:\/\/www.niddk.nih.gov\/health-information\/health-statistics\/overweight-obesity"},{"key":"e_1_3_7_6_1","doi-asserted-by":"publisher","DOI":"10.15620\/cdc\/174643"},{"key":"e_1_3_7_7_1","volume-title":"StatPearls","author":"Lim Y","year":"2025","unstructured":"Lim Y, Haq N, Boster J. Obesity and comorbid conditions. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan- [cited 2024 Jun 27]. PMID: 34662049."},{"key":"e_1_3_7_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(22)00033-X"},{"key":"e_1_3_7_9_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-024-21061-z"},{"key":"e_1_3_7_10_1","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2025.31.2.179"},{"key":"e_1_3_7_11_1","doi-asserted-by":"publisher","DOI":"10.1093\/geroni\/igab046.2348"},{"key":"e_1_3_7_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-2667(17)30074-9"},{"key":"e_1_3_7_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/jgs.17683"},{"key":"e_1_3_7_14_1","doi-asserted-by":"publisher","DOI":"10.2139\/ssrn.3743879"},{"key":"e_1_3_7_15_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41366-023-01376-4"},{"key":"e_1_3_7_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/dom.14863"},{"key":"e_1_3_7_17_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2032183"},{"key":"e_1_3_7_18_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.1831"},{"key":"e_1_3_7_19_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.3224"},{"key":"e_1_3_7_20_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.23619"},{"key":"e_1_3_7_21_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-02026-4"},{"key":"e_1_3_7_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(25)00864-2"},{"key":"e_1_3_7_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/osp4.737"},{"key":"e_1_3_7_24_1","doi-asserted-by":"publisher","DOI":"10.1080\/00325481.2025.2482274"},{"key":"e_1_3_7_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2025.07.018"},{"key":"e_1_3_7_26_1","doi-asserted-by":"publisher","DOI":"10.1080\/13696998.2025.2526282"},{"key":"e_1_3_7_27_1","volume-title":"Presented at Obesity Medicine 2025","author":"Arora P","year":"2025","unstructured":"Arora P, Michalak W, Zhao Z, et al. Medical costs for patients with 12-month continuous semaglutide 2.4 mg use. In: Presented at Obesity Medicine 2025; Maryland: National Harbor; 2025 Apr 23\u201327."},{"key":"e_1_3_7_28_1","unstructured":"Imputing allowed amounts development and validation of an encounter-level allowed amount imputation model. New York (NY): Komodo Health Solutions; 2023 [cited 2025 Feb 6]; Available from: https:\/\/knowledge.komodohealth.com\/hubfs\/2023\/Komodo_Imputing_Allowed_Amounts_White_Paper.pdf"},{"key":"e_1_3_7_29_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12874-017-0445-y"},{"key":"e_1_3_7_30_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13300-024-01678-4"},{"key":"e_1_3_7_31_1","unstructured":"NovoCare\u00ae Pharmacy [Internet]. Bagsvaerd Denmark: Novo Nordisk A\/S; [cited 2025 Mar 17]; Available from:https:\/\/www.novocare.com\/obesity\/products\/wegovy\/get-product.html"},{"key":"e_1_3_7_32_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2306963"},{"key":"e_1_3_7_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/dom.15620"}],"container-title":["Expert Review of Pharmacoeconomics & Outcomes Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14737167.2025.2610206","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T10:19:12Z","timestamp":1778149152000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14737167.2025.2610206"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,12]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2,7]]}},"alternative-id":["10.1080\/14737167.2025.2610206"],"URL":"https:\/\/doi.org\/10.1080\/14737167.2025.2610206","relation":{},"ISSN":["1473-7167","1744-8379"],"issn-type":[{"value":"1473-7167","type":"print"},{"value":"1744-8379","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,12]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierp20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierp20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-11-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-18","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-12","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}